Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
European Radiology|November 28, 2020
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
The Lancet. Infectious Diseases|August 11, 2015
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trialDavid Rey, Lionel Piroth, Marie-Josée Wendling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohortSophie Grabar, Pierre Tattevin, Hana Selinger-Leneman, et al.
AIDS (London, England)|June 5, 2007
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)Lionel Piroth, Damien Sène, Stanislas Pol, et al.
Neuroimage|September 28, 2024
Quantitative brain [<sup>18</sup>F]FDG PET beyond normal blood glucose levelsDavid Rey-Bretal, Lara García-Varela, Noemí Gómez-Lado, et al.
European Radiology|December 23, 2020
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.
AIDS (London, England)|November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infectionRaphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Addiction (Abingdon, England)|April 22, 2017
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohortRod Knight, Perrine Roux, Antoine Vilotitch, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
European Radiology|November 28, 2020
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
The Lancet. Infectious Diseases|August 11, 2015
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trialDavid Rey, Lionel Piroth, Marie-Josée Wendling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2015
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohortSophie Grabar, Pierre Tattevin, Hana Selinger-Leneman, et al.
AIDS (London, England)|June 5, 2007
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)Lionel Piroth, Damien Sène, Stanislas Pol, et al.
Neuroimage|September 28, 2024
Quantitative brain [<sup>18</sup>F]FDG PET beyond normal blood glucose levelsDavid Rey-Bretal, Lara García-Varela, Noemí Gómez-Lado, et al.
European Radiology|December 23, 2020
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?Manuel Piñeiro-Fiel, Alexis Moscoso, Lucía Lado-Cacheiro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.
AIDS (London, England)|November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infectionRaphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Pageof 11